Page last updated: 2024-08-26

combretastatin and Experimental Mammary Neoplasms

combretastatin has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lee, AE; McKeage, MJ; Pruijn, FB; Shalal-Zwain, S; Siim, BG; Wilson, WR	1
Bentzen, L; Bjørnerud, A; Briley-Saebø, K; Horsman, MR; Nielsen, T; Ostergaard, L; Overgaard, J; Vestergaard-Poulsen, P	1

Other Studies

2 other study(ies) available for combretastatin and Experimental Mammary Neoplasms

Article	Year
Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:1 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Carboplatin; Dose-Response Relationship, Drug; Drug Synergism; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Paclitaxel; Stilbenes; Time Factors; Xanthenes; Xanthones	2003
Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor. International journal of radiation oncology, biology, physics, 2005, Mar-15, Volume: 61, Issue:4 Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Hydralazine; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Oxides; Stilbenes; Vasodilator Agents	2005

Article

Year

Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:1

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Carboplatin; Dose-Response Relationship, Drug; Drug Synergism; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Paclitaxel; Stilbenes; Time Factors; Xanthenes; Xanthones

2003

Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.

International journal of radiation oncology, biology, physics, 2005, Mar-15, Volume: 61, Issue:4

Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Hydralazine; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Oxides; Stilbenes; Vasodilator Agents

2005